Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study.

Published in:

HIV Medicine, 2015, v. 16, n. 2, p. 132, doi. 10.1111/hiv.12183

By:

• Gantner, P;
• Reinhart, S;
• Partisani, M;
• Baldeyrou, M;
• Batard, M‐L;
• Bernard‐Henry, C;
• Cheneau, C;
• Mautort, E;
• Priester, M;
• Fafi‐Kremer, S;
• Muret, P;
• Rey, D

Publication type:

Article